Gastric rhythm map to understand stomach problems using a new noninvasive tool
Official title: Definitive Evaluation of Gastric Dysrhythmia as a Disease Mechanism by a Novel Body Surface Gastric Mapping Technique
Funded at University of Louisville · NIH-11611507 · Data updated 2026-11-12
A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project start | July 15, 2024 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $108,000 |
| NIH project number | 3R01DK137790-03S1 |
| Project ID | NIH-11611507 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with functional dyspepsia or chronic nausea and vomiting syndromes who are undergoing evaluation with the BSGM approach.
✕Less likely to help
Patients without gastric symptoms or who cannot participate in noninvasive mapping may not benefit.
What this research studies
This project will use Body Surface Gastric Mapping (BSGM), a painless test, to map the stomach’s electrical activity in adults with functional dyspepsia and related symptoms. By comparing BSGM patterns with patients’ symptoms, researchers hope to identify clear biomarkers that define different forms of gastric dysfunction. The study builds on prior lab work and will analyze data from large clinical studies to determine if dysrhythmias are a key mechanism. If successful, this could lead to better diagnostics and more targeted therapies in the future.
Why it matters
Potential benefit: If successful, patients could receive more accurate diagnoses and personalized treatments for chronic stomach symptoms.
How similar studies have gone: Prior work with BSGM has shown promising biomarkers and spatial patterns not detectable by older methods.
Where this research is happening
-
University of Louisville
Louisville, United States Active
Researchers
- Principal investigator: Abell, Thomas Lyman — University of Louisville
- Study coordinator: Abell, Thomas Lyman
Related research
Other NIH-funded projects on the same topics.
-
Novel antivirals for alphavirus arthritis
A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.
-
Linking heavy metal exposure to a tougher breast cancer type (TNBC)
Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.
-
Cardiac safety of flavored e-cigarette aerosols in adults
A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.
-
Biomedical Research Facilities to Expand Precision Medicine in Kentucky
A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.
-
Rac-enhanced CAR-Macrophages against TNBC
A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.
-
How vitamin B12 helps the gum-disease bacterium survive
Learning how vitamin B12 helps the bacteria that cause gum disease survive and become more harmful for people with periodontitis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.